Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. 2011

Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
Department of Rheumatology and Clinical Immunology, University Medical Centre, University of Groningen, Groningen, The Netherlands. lodewijk.de.groot@reuma.umcg.nl

BACKGROUND Advanced glycation end products (AGEs) are produced and can accumulate during chronic inflammation, as might be present in patients with rheumatoid arthritis (RA). AGEs are involved in the development of cardiovascular disease. The aim of this study is to evaluate whether AGEs are increased in patients with long-standing RA and whether AGE accumulation is related to disease activity, disease severity and measures of (premature) atherosclerosis, such as endothelial activation, endothelial dysfunction and intima media thickness (IMT). METHODS In a cross-sectional study, 49 consecutive RA patients with longstanding disease (median disease duration of 12.3 years (range 9.3 to 15.1)), receiving standard of care, were included and compared with 49 age- and sex-matched healthy controls (HC). AGEs were determined by skin autofluorescence. Disease activity was evaluated by the Disease Activity Score of 28 joints (DAS-28) score and joint damage by modified Sharp-v.d. Heijde score. Endothelial activation (soluble vascular cellular adhesion molecule-1) sVCAM-1, von Willebrand factor (vWF), thrombomodulin), endothelial dysfunction (determined by small artery elasticity (SAE)) and IMT were measured and related to AGE accumulation. RESULTS AGEs were increased in RA patients (median 2.4 arbitrary units (a.u.), range 1.6 to 4.2) compared to HC (2.2, 1.3 to 3.8). RA patients had a DAS-28 score of 2.9 (0.8 to 6.9) and a modified Sharp-v.d. Heijde score of 19 (0 to 103). sVCAM-1 and vWF levels were higher in RA patients. SAE was significantly decreased in RA (3.9 ml/mmHg (1.4 to 12.2) vs. 6.1 in HC (1.7 to 12.9). IMT did not differ between the two groups. Combining both groups' AGEs correlated with vWF, sVCAM-1 and IMT, and was inversely related to SAE. In RA, AGEs had an inverse relation with SAE, but did not relate to disease activity or radiological damage. In multivariate analysis for both groups, smoking, glucose levels, vWF, SAE and male gender were significantly related to the formation of AGEs. CONCLUSIONS AGEs were increased in RA patients with long-standing disease and without signs of premature atherosclerosis. AGEs were related to endothelial activation and endothelial dysfunction. This supports the hypothesis that in RA AGEs may be an early marker of cardiovascular disease.

UI MeSH Term Description Entries
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
March 2010, Annals of the rheumatic diseases,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
June 1998, Brain research,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
January 2014, Clinical chemistry and laboratory medicine,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
July 2012, International journal of cardiology,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
February 2013, Current opinion in lipidology,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
August 2007, Naunyn-Schmiedeberg's archives of pharmacology,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
January 1998, Vascular medicine (London, England),
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
February 1997, Brain research. Brain research reviews,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
November 2013, The Journal of pediatrics,
Lodewijk de Groot, and Helmy Hinkema, and Johanna Westra, and Andries J Smit, and Cees G M Kallenberg, and Marc Bijl, and Marcel D Posthumus
March 2006, Sleep,
Copied contents to your clipboard!